Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookThe Kenya National Drug Policy (WHO; 1994; 27 pages)
View the documentFOREWORD
View the documentABBREVIATIONS
Open this folder and view contents1. GOAL AND OBJECTIVES OF THE NATIONAL DRUG POLICY
Open this folder and view contents2. PUBLIC SECTOR DRUG SUPPLY
close this folder3. DRUG SUPPLY BY THE PRIVATE SECTOR & NON-GOVERNMENTAL ORGANISATIONS
View the document3.1. Adoption of the Essential Drugs Concept
View the document3.2. Generic Labelling
View the document3.3. Institutional and Retail Pharmacy Services
View the document3.4. Prescribing and Dispensing
View the document3.5. Drug Donations
View the document3.6. Financing and Pricing of Drugs in the Private and NGO Sectors
Open this folder and view contents4. VETERINARY DRUG SUPPLY
Open this folder and view contents5. REGULATORY CONTROL
Open this folder and view contents6. RATIONAL DRUG USE
Open this folder and view contents7. QUALITY ASSURANCE
View the document8. DRUG ABUSE
Open this folder and view contents9. IMPORTATION AND EXPORTATION OF DRUGS
Open this folder and view contents10. LOCAL PRODUCTION
View the document11. MANPOWER TRAINING AND DEVELOPMENT
View the document12. LEGISLATION
View the document13. MONITORING & EVALUATION
View the document14. INTERSECTORAL AND TECHNICAL COOPERATION
 

3.6. Financing and Pricing of Drugs in the Private and NGO Sectors

Programmes will be developed to provide for payment of prescription drugs through the National Hospital Insurance Fund, NSSF and/or private health insurance. The private and public sectors will promote a viable and sustainable medical insurance scheme as a mutual commitment to a comprehensive social welfare programme.

Alternatives to the current tariff (percent mark-up) system of compensating pharmacists/pharmaceutical technologists will be explored to find ways of making Pharmaceuticals more affordable.

To encourage cost awareness, all drug distributors and manufacturers will be required to provide their local wholesale price list to the Ministry of Health according to an established timetable. The Ministry will publish these official prices at least once yearly and more often as appropriate. In addition, a mechanism will be established to exchange information with other countries on prices of individual pharmaceutical products.

Generic prescribing and substitution as well as selective drug registration should also control the usual drug costs paid by patients.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French